Literature DB >> 11989786

Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles.

Huai-Rong Luo1, Xue-Mei Lü, Yong-Gang Yao, Nobuyuki Horie, Keiichi Takeishi, Lynn B Jorde, Ya-Ping Zhang.   

Abstract

The tandemly repeated 28-bp sequence in the 5'-terminal regulatory region of human thymidylate synthase (TSER), which has been reported to be polymorphic in different populations, was surveyed in 668 Chinese from 9 Han groups, 8 ethnic populations, and 36 individuals representing a three-generation pedigree. Amplified fragments were separated by electrophoresis on 4% agarose gel. In addition to the reported double and triple repeats of the 28-bp sequence in TSER, we also detected a novel quintuple repeat in this region. The transient expression activity of TSER with the quintuple repeat is almost the same as that of the reported TSER with the triple repeat. All three alleles of the repeat type (2, 3, and 5) were further confined by sequencing. The frequencies of the TSER allele 2 and 3 were 18.82 and 81% in totally unrelated Chinese samples, respectively, while the frequency of allele 3 was variable in different Chinese populations with a range from 62 to 95%. On the basis of the sequences of the different alleles, the existence of the tandem repeats in each allele might be explained by slipped-strand mispairing during DNA replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11989786     DOI: 10.1023/a:1014589105977

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  11 in total

1.  TYMS and DPYD polymorphisms in a Turkish population.

Authors:  H S Süzen; N Yüce; G Güvenç; Y Duydu; T Erke
Journal:  Eur J Clin Pharmacol       Date:  2005-11-17       Impact factor: 2.953

2.  Genetic variants in the enhancer region of the thymidylate synthase gene in the Chilean population.

Authors:  M Acuña; L Eaton; L Cifuentes; D Massardo
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

3.  Reexamining a proposal: thymidylate synthase 5'-untranslated region as a regulator of translation efficiency.

Authors:  Soma Ghosh; Jordan M Winter; Kalpesh Patel; Scott E Kern
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

Review 4.  Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-06-09

5.  Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.

Authors:  Souhir Chaabane; Sameh Marzouk; Rim Akrout; Mariem Ben Hamad; Yosser Achour; Ahmed Rebai; Leila Keskes; Hela Fourati; Zouhir Bahloul; Abdellatif Maalej
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-08       Impact factor: 2.441

Review 6.  Thymidylate synthase pharmacogenetics.

Authors:  Sharon Marsh
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

7.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 8.  Impact of pharmacogenomics on clinical practice in oncology.

Authors:  Sharon Marsh
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Genetic variation in genes involved in folate and drug metabolism in a south Indian population.

Authors:  Padmalatha S Rai; T S Murali; T G Vasudevan; Shama K Prasada; Ashok Kumar Bhagavath; Pranita Pai; P M Gopinath; K Satyamoorthy
Journal:  Indian J Hum Genet       Date:  2011-05

10.  A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Authors:  J Stoehlmacher; D J Park; W Zhang; D Yang; S Groshen; S Zahedy; H-J Lenz
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.